UCB in Portugal
Web: https://www.ucb.com/
Address:
-
UCB Pharma (Produtos Farmacêuticos) Lda.
Rua do Silval, nº 37, piso 1, S1.3 P -2780-373 Oeiras
Phone: +351 21 302 5300
Fax: +351 21 301 7103
Other UCB's locations around the world
Clinical Trials sponsored by UCB
-
UCB CelltechTerminadoEnfermedad de CrohnEstados Unidos, Canadá, Nueva Zelanda, Australia
-
UCB CelltechTerminadoPsoriasis leve a moderadaReino Unido
-
UCB CelltechTerminadoVoluntarios SaludablesReino Unido
-
UCB BIOSCIENCES, Inc.UCB Biopharma SRLTerminadoEpilepsiaEstados Unidos, Argentina, Australia, Bélgica, Brasil, Bulgaria, Porcelana, Colombia, Croacia, Chequia, Estonia, Francia, Georgia, Grecia, Hungría, Israel, Italia, Corea, república de, Letonia, Lituania, México, Moldavia, República de, Montenegr... y más
-
UCB Biopharma SRLReclutamientoMiastenia Gravis GeneralizadaItalia, Estados Unidos, Corea, república de
-
UCB Biopharma SRLReclutamientoEnfermedad asociada a anticuerpos de glicoproteína de oligodendrocitos de mielina (MOG-AD)Estados Unidos, Australia, Bélgica, Chequia, Francia, Alemania, Italia, Japón, Corea, república de, México, España, Suecia, Suiza, Pavo, Portugal, Reino Unido, Brasil, Ucrania, Taiwán
-
UCB Biopharma SRLInscripción por invitaciónConvulsiones prolongadas estereotipadasEstados Unidos, Bulgaria, Porcelana, Chequia, Alemania, Hungría, Italia, Japón, Polonia, España, Reino Unido, Australia
-
UCB Biopharma SRLActivo, no reclutandoEspondiloartritis anquilosante | Espondiloartritis axial | r-axSpa | Nr-axSpaEstados Unidos, Bélgica, Bulgaria, Porcelana, Chequia, Francia, Alemania, Hungría, Japón, Países Bajos, Polonia, España, Pavo, Reino Unido
-
UCB Biopharma SRLActivo, no reclutandoLupus eritematoso sistémicoEstados Unidos, Argentina, Australia, Austria, Bélgica, Bulgaria, Canadá, Chile, Colombia, Chequia, Dinamarca, Francia, Alemania, Grecia, Hungría, Italia, Corea, república de, México, Perú, Filipinas, Polonia, Rumania, Serbia, España, Taiwán
-
UCB Biopharma SRLActivo, no reclutando
About UCB
A global biopharma company, focusing on neurology and immunology. Our business is strong. Total revenue grew to €4.9 billion in 2019. We are more than 7,600 people in all four corners of the globe, inspired by patients and driven by science. UCB’s ambition is to transform the lives of people living with severe diseases. We focus on neurology and immunology disorders – putting patients at the center of our world. We are Inspired by Patients. Driven by Science. UCB is continuously working to advance science and embrace new knowledge. We are leveraging scientific advances and skills in areas such as genetics, biomarkers and human biology. Patients inspire us to bring them value through cutting-edge science, innovative drugs, and practical solutions – so that they and their carers can get on with their lives